The inhibitory effect of quercetin-3-glucuronide on pulmonary injury in vitro and in vivo
Journal of Food and Drug Analysis · 15.06.2023 · 31 (2) · 254-277
DOI: 10.38212/2224-6614.3453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 15.06.2023. Verfasst von Pei-Rong Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Chung Shan Medical University, Taichung City, 40201, Taiwan. Hauptthemen laut MEDLINE: Lung Injury. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Pulmonary injury is defined as a progressive inflammation. Extensive pro-inflammatory cytokines are secreted from alveolus, associated with the production of reactive oxygen species (ROS) and apoptosis. The model of endotoxin lipopolysaccharide (LPS)-stimulated lung cells has been applied to mimic the pulmonary injury. Some antioxidants and anti-inflammatory compounds can be used as chemopreventive agents of pulmonary injury. Quercetin-3-glucuronide (Q3G) has been showed to exert antioxidant, anti-inflammatory, anti-cancer, anti-aging and anti-hypertension effects. The aim of the study is to examine the inhibitory potential of Q3G on pulmonary injury and inflammation in vitro and in vivo. Firstly, human lung fibroblasts MRC-5 cells pre-treated with LPS were demonstrated to cause survival loss and ROS generation, were recovered by Q3G. Q3G also exhibited the anti-inflammatory effects on the LPS-treated cells with a reduction in the activation of NLRP3 [nucleotide-binding and oligomerization domain (NOD)-like receptor protein 3] inflammasome, leading to pyroptosis. Also, Q3G showed the anti-apoptotic effect in the cells might be mediated via inhibition of mitochondrial apoptosis pathway. To further explore in vivo pulmonary-protective effect of Q3G, C57BL/6 mice were intranasally exposed to a combination of LPS and elastase (LPS/E) to perform the pulmonary injury model. The results revealed that Q3G ameliorated pulmonary function parameters and lung edema in the LPS/E-induced mice. Q3G also suppressed the LPS/E-stimulated inflammation, pyroptosis and apoptosis in the lungs. Taken together, this study suggested the lung-protective potential of Q3G via downregulation of inflammation, pyroptotic and apoptotic cell death, contributing to its chemopreventive activity of pulmonary injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, Chung Shan Medical University, Taichung City, 40201, Taiwan.
- Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
- Clinical Laboratory, Chung Shan Medical University Hospital, Taichung City, 40201, Taiwan.
- Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung City, 40201, Taiwan.
Zitieren
APA
Yu, P. R., Hsu, J. Y., Tseng, C. Y., Chen, J. H., & Lin, H. H. (2023). The inhibitory effect of quercetin-3-glucuronide on pulmonary injury in vitro and in vivo. Journal of Food and Drug Analysis, 31(2), 254-277. https://doi.org/10.38212/2224-6614.3453
Vancouver
Yu PR, Hsu JY, Tseng CY, Chen JH, Lin HH. The inhibitory effect of quercetin-3-glucuronide on pulmonary injury in vitro and in vivo. Journal of Food and Drug Analysis. 2023;31(2):254-277. doi:10.38212/2224-6614.3453
BibTeX
@article{Yu2023,
author = {Yu, Pei-Rong and Hsu, Jen-Ying and Tseng, Chiao-Yun and Chen, Jing-Hsien and Lin, Hui-Hsuan},
title = {The inhibitory effect of quercetin-3-glucuronide on pulmonary injury in vitro and in vivo},
journal = {Journal of Food and Drug Analysis},
year = {2023},
volume = {31},
number = {2},
pages = {254--277},
doi = {10.38212/2224-6614.3453}
}
EUVIMED